The Hague, Oct 25 (EFE).- The European Medicines Agency approved on Monday a third dose of the Moderna vaccine for people over the age of 18, the organization announced.
The EMA said it had approved the booster shot after data showed that “a third dose of Spikevax given 6 to 8 months after the second dose led to a rise in antibody levels in adults whose antibody levels were waning.”
The booster jab will contain half the dose used in the preliminary shots and side effects would be similar to those after the second shot.
“The risk of inflammatory heart conditions or other very rare side effects after a booster is being carefully monitored,” the agency said in a statement.
Earlier this month, EMA approved a third shot of the Pfizer/BioNTech and Moderna for people with compromised immune systems and left it to EU Member States to decide whether to offer the booster shot to the general adult population. EFE